A detailed history of Occam Crest Management LP transactions in Precigen, Inc. stock. As of the latest transaction made, Occam Crest Management LP holds 2,697,400 shares of PGEN stock, worth $12.4 Million. This represents 5.4% of its overall portfolio holdings.

Number of Shares
2,697,400
Holding current value
$12.4 Million
% of portfolio
5.4%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.43 - $4.76 $3.86 Million - $12.8 Million
2,697,400 New
2,697,400 $8.87 Billion

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $960M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Occam Crest Management LP Portfolio

Follow Occam Crest Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occam Crest Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Occam Crest Management LP with notifications on news.